CI & Patent News: 18/11/2010


1) Pfizer to market off-patent medicines in Philippines. Pfizer Parke Davis, a new unit will be launching nine generic medicines in Anti-infective, Hypertension and vertigo. (Philstar)

2) Zafirlukast: DRL ANDA does not infringe Astrazeneca’s asserted patents (law360). Paroduct and MOT patents are expired on Sep 2010.

3) Paragraph IV Litigation

Darunavir: Tibotec Vs Lupin & Mylan (on 15 Nov 2010) and in another case, Univ of Illinois has sued Mylan and Lupin for 7470506 (on 17 Nov 2010)

4) FDA Approves Shire plc’s Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII for the Treatment of ADHD in Adolescents (Biospace)

Advertisements

About Guna

Interested to learn things around me
This entry was posted in Daily interesting IP news. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s